IMPORTANCE: The use of proton pump inhibitors (PPIs) has rapidly increased during the past several years. However, concern remains about risks associated with their long-term use in older populations. OBJECTIVE: To investigate the relationship between the use of PPIs and the risk of death or the combined end point of death or rehospitalization in older patients discharged from acute care hospitals. DESIGN: We investigated the relationship between PPI use and study outcomes using time-dependent Cox proportional hazards regression in patients 65 years or older discharged from acute care medical wards from April 1 to June 30, 2007. SETTING: Eleven acute care medical wards. PARTICIPANTS: Four hundred ninety-one patients (mean [SD] age, 80.0 [5.9] years). MAIN OUTCOME MEASURES: Mortality and the combined end point of death or rehospitalization. RESULTS The use of PPIs was independently associated with mortality (hazard ratio, 1.51 [95% CI, 1.03-2.77]) but not with the combined end point (1.49 [0.98-2.17]). An increased risk of mortality was observed among patients exposed to high-dose PPIs vs none (hazard ratio, 2.59 [95% CI, 1.22-7.16]). CONCLUSIONS AND RELEVANCE: In older patients discharged from acute care hospitals, the use of high-dose PPIs is associated with increased 1-year mortality. Randomized controlled studies including older frail patients are needed. In the meantime, physicians need to use caution and balance benefits and harms in long-term prescription of high-dose PPIs.
IMPORTANCE: The use of proton pump inhibitors (PPIs) has rapidly increased during the past several years. However, concern remains about risks associated with their long-term use in older populations. OBJECTIVE: To investigate the relationship between the use of PPIs and the risk of death or the combined end point of death or rehospitalization in older patients discharged from acute care hospitals. DESIGN: We investigated the relationship between PPI use and study outcomes using time-dependent Cox proportional hazards regression in patients 65 years or older discharged from acute care medical wards from April 1 to June 30, 2007. SETTING: Eleven acute care medical wards. PARTICIPANTS: Four hundred ninety-one patients (mean [SD] age, 80.0 [5.9] years). MAIN OUTCOME MEASURES: Mortality and the combined end point of death or rehospitalization. RESULTS The use of PPIs was independently associated with mortality (hazard ratio, 1.51 [95% CI, 1.03-2.77]) but not with the combined end point (1.49 [0.98-2.17]). An increased risk of mortality was observed among patients exposed to high-dose PPIs vs none (hazard ratio, 2.59 [95% CI, 1.22-7.16]). CONCLUSIONS AND RELEVANCE: In older patients discharged from acute care hospitals, the use of high-dose PPIs is associated with increased 1-year mortality. Randomized controlled studies including older frail patients are needed. In the meantime, physicians need to use caution and balance benefits and harms in long-term prescription of high-dose PPIs.
Authors: Shelly L Gray; Andrea Z LaCroix; Joseph Larson; John Robbins; Jane A Cauley; JoAnn E Manson; Zhao Chen Journal: Arch Intern Med Date: 2010-05-10
Authors: J Simon Bell; Timo E Strandberg; Mariko Teramura-Gronblad; Jouko V Laurila; Reijo S Tilvis; Kaisu H Pitkälä Journal: Arch Intern Med Date: 2010-09-27
Authors: Alberto Pilotto; Marilisa Franceschi; Gioacchino Leandro; Carlo Scarcelli; Luigi P D'Ambrosio; Davide Seripa; Francesco Perri; Valeria Niro; Francesco Paris; Angelo Andriulli; Francesco Di Mario Journal: J Am Geriatr Soc Date: 2006-10 Impact factor: 5.562
Authors: Ulrich M Vischer; Emilia Frangos; Christophe Graf; Gabriel Gold; Lucien Weiss; François R Herrmann; Dina Zekry Journal: Clin Nutr Date: 2011-10-11 Impact factor: 7.324
Authors: Mette Charlot; Erik L Grove; Peter Riis Hansen; Jonas B Olesen; Ole Ahlehoff; Christian Selmer; Jesper Lindhardsen; Jan Kyst Madsen; Lars Køber; Christian Torp-Pedersen; Gunnar H Gislason Journal: BMJ Date: 2011-05-11
Authors: Alberto Pilotto; Franco Rengo; Niccolò Marchionni; Daniele Sancarlo; Andrea Fontana; Francesco Panza; Luigi Ferrucci Journal: PLoS One Date: 2012-01-11 Impact factor: 3.240
Authors: Siri A Tvingsholm; Christian Dehlendorff; Kell Østerlind; Søren Friis; Marja Jäättelä Journal: Int J Cancer Date: 2018-05-02 Impact factor: 7.396
Authors: R Schepisi; S Fusco; F Sganga; B Falcone; D L Vetrano; A Abbatecola; F Corica; M Maggio; C Ruggiero; P Fabbietti; A Corsonello; G Onder; F Lattanzio Journal: J Nutr Health Aging Date: 2016 Impact factor: 4.075
Authors: Matthew A Pegoli; Maneesha Dedigama; Arduino A Mangoni; Patrick T Russell; Luke E Grzeskowiak; Tilenka Thynne Journal: Ther Adv Drug Saf Date: 2016-11-29